Loading stock data...

Vimta Labs Limited

NSE: VIMTALABS BSE: VIMTALABS

NSE
462.25 -2.50 (-0.54%)

Prev Close

464.75

Open Price

462.05

Volume

154,294

Today Low / High

452.3 / 470.45

52 WK Low / High

400.3 / 902.65

Range

439 - 485

BSE
465.95 1.20 (0.26%)

Prev Close

464.75

Open Price

463.95

Volume

3,218

Today Low / High

452.55 / 470.35

52 WK Low / High

372.5 / 902.85

Range

443 - 489

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 462.25 (target range: 439 - 485), reflecting a change of -2.5 (-0.53792%). On the BSE, it is listed at 465.95 (target range: 443 - 489), showing a change of 1.2 (0.2582%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

20 Feb 474.95 -1.19%
19 Feb 491.00 -3.11%
18 Feb 498.20 -1.75%
17 Feb 471.20 5.24%
16 Feb 466.05 0.93%
13 Feb 483.35 -3.26%
12 Feb 485.00 1.18%
11 Feb 467.10 5.15%
10 Feb 458.00 1.89%
09 Feb 424.60 6.98%
06 Feb 432.70 -1.87%
05 Feb 450.10 -4.49%
04 Feb 456.35 -1.85%
03 Feb 451.00 -2.78%
02 Feb 442.00 -1.45%
01 Feb 411.35 7.66%
30 Jan 412.00 -0.23%
29 Jan 456.00 -7.34%
28 Jan 511.15 -10.70%

Vimta Labs Limited Graph

Vimta Labs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Vimta Labs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 462.25, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 465.95 470.61 423.55 - 517.67
475.27 380.22 - 570.32
479.93 335.95 - 623.91
Bearish Scenario 465.95 461.29 415.16 - 507.42
456.63 365.30 - 547.96
451.97 316.38 - 587.56

Overview of Vimta Labs Limited

ISIN

INE579C01029

Industry

Medical - Diagnostics & Research

Vol.Avg

214,575

Market Cap

20,947,294,198

Last Dividend

1

Official Website

Visit Website

IPO Date

2005-12-15

DCF Diff

-868.78

DCF

1,359

Financial Ratios Every Investor Needs

Stock Dividend of VIMTALABS

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-05-30 May 30, 25 1 1 2025-05-30 2025-06-16
2024-07-11 July 11, 24 2 2 2024-07-11 2024-07-25
2023-06-21 June 21, 23 2 2 2023-06-21 2023-07-07
2022-06-16 June 16, 22 2 2 2022-06-18 2022-06-30
2021-06-25 June 25, 21 2 2 2021-06-28 2021-07-12

Stock Rating Details for VIMTALABS

Metric Value Recommendation
Overall Rating C Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 343.98 Cr 211.38 Cr 132.60 Cr 0.3855 0.00 Cr 100.59 Cr 87.82 Cr 67.34 Cr 15.14 126.19 Cr 0.1958
2024-03-31 318.26 Cr 76.29 Cr 241.98 Cr 0.7603 0.00 Cr 10.28 Cr 61.90 Cr 41.01 Cr 9.26 90.20 Cr 0.1289
2023-03-31 315.06 Cr 73.85 Cr 241.21 Cr 0.7656 0.00 Cr 10.93 Cr 69.68 Cr 48.17 Cr 10.89 96.64 Cr 0.1529
2022-03-31 275.94 Cr 184.53 Cr 91.41 Cr 0.3313 0.00 Cr 8.60 Cr 55.33 Cr 41.33 Cr 9.35 80.27 Cr 0.1498
2021-03-31 208.57 Cr 61.11 Cr 147.45 Cr 0.7070 1.12 Cr 66.33 Cr 36.08 Cr 21.41 Cr 4.84 53.35 Cr 0.1026

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 15.84 Cr 466.53 Cr 87.68 Cr 378.8480 Cr 8.52 Cr -7.32 Cr 25.06 Cr 261.67 Cr 0.00 Cr 8.22 Cr 0.00 Cr 64.3670 Cr
2024-03-31 13.44 Cr 400.05 Cr 80.35 Cr 319.6960 Cr 19.19 Cr 5.75 Cr 24.69 Cr 216.75 Cr 0.00 Cr 5.33 Cr -9.36 Cr 54.0700 Cr
2023-03-31 30.50 Cr 362.33 Cr 80.54 Cr 281.7860 Cr 14.99 Cr -15.51 Cr 22.62 Cr 171.67 Cr 4.90 Cr 4.52 Cr -6.00 Cr 57.2770 Cr
2022-03-31 10.80 Cr 307.20 Cr 73.21 Cr 233.9840 Cr 19.34 Cr 8.54 Cr 17.38 Cr 150.86 Cr 4.79 Cr 5.58 Cr 0.00 Cr 47.7490 Cr
2021-03-31 6.19 Cr 274.36 Cr 79.98 Cr 194.3820 Cr 30.42 Cr 24.22 Cr 14.64 Cr 147.95 Cr 4.14 Cr 3.84 Cr 0.00 Cr 53.9110 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 94.8300 Cr -75.5370 Cr -16.6810 Cr 15.7660 Cr 2.3950 Cr 15.8360 Cr -79.4940 Cr 66.7550 Cr -10.9260 Cr -4.4340 Cr -0.3660 Cr
2024-03-31 60.8920 Cr -76.0480 Cr -1.9030 Cr -15.6780 Cr -17.0590 Cr 13.4410 Cr -76.3340 Cr 41.0090 Cr 4.0010 Cr -4.4280 Cr -2.0680 Cr
2023-03-31 87.9370 Cr -57.2560 Cr -10.9810 Cr 38.1320 Cr 19.7000 Cr 30.5000 Cr -47.8190 Cr 64.9970 Cr -5.6780 Cr -4.4220 Cr -5.2460 Cr
2022-03-31 59.0690 Cr -37.8480 Cr -16.6140 Cr 20.3450 Cr 4.6070 Cr 10.8000 Cr -29.7830 Cr 55.6850 Cr -11.4150 Cr -4.4220 Cr -2.7420 Cr
2021-03-31 37.1820 Cr -31.9240 Cr -4.5700 Cr 4.0930 Cr 0.6880 Cr 6.1930 Cr -33.0890 Cr 28.5400 Cr -2.8450 Cr 0.0000 Cr 2.4950 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 98.63 Cr 58.69 Cr 39.95 Cr 0.4050 23.31 Cr 17.59 Cr 3.96 34.45 Cr 0.1783
2025-09-30 101.85 Cr 20.15 Cr 81.70 Cr 0.8022 23.99 Cr 19.92 Cr 4.46 36.89 Cr 0.1956
2025-06-30 97.56 Cr 56.49 Cr 41.08 Cr 0.4210 23.83 Cr 18.89 Cr 4.25 35.44 Cr 0.1937
2025-03-31 94.44 Cr 54.65 Cr 39.79 Cr 0.4213 23.83 Cr 18.32 Cr 4.11 34.68 Cr 0.1940
2024-12-31 89.92 Cr 20.63 Cr 69.29 Cr 0.7706 23.28 Cr 21.50 Cr 4.83 34.31 Cr 0.2390

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 28.14 Cr 28.32 Cr 56.46 Cr 107.22 Cr 28.60 Cr 212.82 Cr 288.59 Cr 518.16 Cr 101.77 Cr
2025-06-30 0.00 Cr 0.00 Cr 32.32 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -378.85 Cr
2025-03-31 15.84 Cr 16.89 Cr 32.72 Cr 106.32 Cr 25.06 Cr 187.82 Cr 261.67 Cr 466.53 Cr 87.68 Cr
2024-12-31 0.00 Cr 0.00 Cr 27.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -342.74 Cr
2024-09-30 14.27 Cr 15.84 Cr 30.11 Cr 92.67 Cr 26.33 Cr 171.94 Cr 244.53 Cr 440.41 Cr 97.67 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 18.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 17.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 21.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 15.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 12.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2006-02-24 February 24, 06 5:1

Similar Stocks: Medical - Diagnostics & Research

Company Name Symbol Price Market Cap Volume
Dr. Lal PathLabs Limited LALPATHLAB ₹1,409.10 ₹235,282,322,213.00 ₹252,705.00
Sai Life Sciences Ltd. SAILIFE ₹942.90 ₹199,544,767,233.00 ₹451,378.00
Vijaya Diagnostic Centre Limited VIJAYA ₹986.00 ₹101,286,790,840.00 ₹87,898.00
Metropolis Healthcare Limited METROPOLIS ₹1,894.60 ₹98,200,717,740.00 ₹29,031.00

Key Executives

Executive Chairman
Sivalinga Prasad Vasireddi

Gender: Not Specified

Year Born: 1948

Senior Vice President of Preclinical
Upendra Bhatnagar

Gender: Not Specified

Year Born:

Executive Director of Operations, Member of Scientific Advisory Board & Executive Director
Harriman Vungal D.Tech

Gender: male

Year Born: 1951

Executive Director
Satya Sreenivas Neerukonda

Gender: male

Year Born: 1976

Chief Financial Officer
Siva Rama Krishna Kambhampati

Gender: male

Year Born:

MD & Whole Time Director
Harita Vasireddi

Gender: female

Year Born: 1974

Company Secretary & Compliance Officer
Sujani Vasireddi

Gender: female

Year Born: 1976

FAQs about Vimta Labs Limited

Who is the CEO of the company?

The CEO is Sivalinga Prasad Vasireddi.

What is the current market price of the stock?

The current price is ₹469.30.

What is the 52-week price range?

The range is ₹400.3-902.65.

What is the market capitalization of the company?

The market capitalization is ₹2,094.73 crores.

What is the dividend yield?

The dividend yield is 0.21%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 27.89.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Vimta Labs Limited (ISIN: INE579C01029) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹2,094.73 crores and an average daily volume of 214,575 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹1.